Literature DB >> 23607661

Impaired brain activity in cirrhotic patients with minimal hepatic encephalopathy: Evaluation by near-infrared spectroscopy.

Hiroyuki Nakanishi1, Masayuki Kurosaki, Kaoru Nakanishi, Kaoru Tsuchiya, Takamasa Noda, Nobuharu Tamaki, Yutaka Yasui, Takanori Hosokawa, Ken Ueda, Jun Itakura, Kimitaka Anami, Yasuhiro Asahina, Nobuyuki Enomoto, Teruhiko Higuchi, Namiki Izumi.   

Abstract

AIM: Near-infrared spectroscopy (NIRS) is a tool that could non-invasively measure the regional cerebral oxygenated hemoglobin (oxy-Hb) concentration with high time resolution. The aim of the present study is to reveal the time-dependent regional cerebral oxy-Hb concentration change coupled with brain activity during task performance in patients with minimal hepatic encephalopathy (MHE).
METHODS: Cerebral oxy-Hb concentration was measured by using NIRS in 29 cirrhotic patients without overt hepatic encephalopathy (HE). Of those, 16 patients who had abnormal electroencephalography findings were defined as having MHE. Responsive increase in oxy-Hb during a word-fluency task was compared between MHE and non-MHE patients.
RESULTS: There was no difference in the maximum value of oxy-Hb increase between patients with and without MHE (0.26 ± 0.12 vs 0.32 ± 0.22 mM·mm, P = 0.37). However, the pattern of the time course changes of oxy-Hb was different between the two groups. The MHE group was characterized by a gradual increase of oxy-Hb throughout the task compared to steep and repetitive increase in the non-MHE group. Increase in oxy-Hb concentration at 5 s after starting the task was significantly small in the MHE group compared to the non-MHE (0.03 ± 0.05 vs 0.11 ± 0.09 mM·mm, P = 0.006).
CONCLUSION: The cerebral oxygen concentration is poorly reactive in response to tasks among cirrhotic patients without overt HE but having abnormal electroencephalography findings. These impaired responses in regional cerebral oxy-Hb concentration may be related to the latent impairment of brain activity seen in MHE.
© 2013 The Japan Society of Hepatology.

Entities:  

Keywords:  hepatic encephalopathy; near-infrared spectroscopy

Year:  2013        PMID: 23607661     DOI: 10.1111/hepr.12127

Source DB:  PubMed          Journal:  Hepatol Res        ISSN: 1386-6346            Impact factor:   4.288


  6 in total

1.  Altered cortical brain activity in end stage liver disease assessed by multi-channel near-infrared spectroscopy: Associations with delirium.

Authors:  Atsushi Yoshimura; Carrie Goodson; Jordan T Johns; Maxwell M Towe; Esme S Irvine; Nada A Rendradjaja; Laura K Max; Andrew LaFlam; Emily C Ledford; Julia Probert; Zoë Tieges; David H Edwin; Alasdair M J MacLullich; Charles W Hogue; Martin A Lindquist; Ahmet Gurakar; Karin J Neufeld; Atsushi Kamiya
Journal:  Sci Rep       Date:  2017-08-23       Impact factor: 4.379

2.  Multi-Sensory Integration Impairment in Patients with Minimal Hepatic Encephalopathy.

Authors:  Kyoungwon Seo; Dae Won Jun; Jae-Kwan Kim; Hokyoung Ryu
Journal:  Sci Rep       Date:  2017-11-02       Impact factor: 4.379

3.  Reduced brain activity in female patients with non-alcoholic fatty liver disease as measured by near-infrared spectroscopy.

Authors:  Atsushi Takahashi; Soichi Kono; Akira Wada; Sachie Oshima; Kazumichi Abe; Hiromichi Imaizumi; Masashi Fujita; Manabu Hayashi; Ken Okai; Itaru Miura; Hirooki Yabe; Hiromasa Ohira
Journal:  PLoS One       Date:  2017-04-04       Impact factor: 3.240

Review 4.  Endothelial and microvascular function in liver cirrhosis: an old concept that needs re-evaluation?

Authors:  Ioanna Papagiouvanni; Pantelis Sarafidis; Marieta P Theodorakopoulou; Emmanouil Sinakos; Ioannis Goulis
Journal:  Ann Gastroenterol       Date:  2022-07-15

5.  Machine Learning Classification of Cirrhotic Patients with and without Minimal Hepatic Encephalopathy Based on Regional Homogeneity of Intrinsic Brain Activity.

Authors:  Qiu-Feng Chen; Hua-Jun Chen; Jun Liu; Tao Sun; Qun-Tai Shen
Journal:  PLoS One       Date:  2016-03-15       Impact factor: 3.240

6.  Impaired brain function improved by L-carnitine in patients with cirrhosis: evaluation using near-infrared spectroscopy.

Authors:  Hiroyuki Nakanishi; Yuka Hayakawa; Youhei Kubota; Masayuki Kurosaki; Leona Osawa; Kento Inada; Sakura Kirino; Koji Yamashita; Shuhei Sekiguchi; Mao Okada; Wang Wan; Mayu Higuchi; Kenta Takaura; Chiaki Maeyashiki; Shun Kaneko; Nobuharu Tamaki; Yutaka Yasui; Takamasa Noda; Kaoru Nakanishi; Kaoru Tsuchiya; Jun Itakura; Yuka Takahashi; Namiki Izumi
Journal:  Sci Rep       Date:  2020-08-11       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.